Foxp3⁺ Regulatory T Cells Associated With CCL17/CCR4 Expression in Carcinomas of Dogs
2020
Maeda, Shingo | Nakazawa, Maho | Uchida, Mona | Yoshitake, Ryohei | Nakagawa, Takayuki | Nishimura, Ryohei | Miyamoto, Ryo | Bonkobara, Makoto | Yonezawa, Tomohiro | Momoi, Yasuyuki
Regulatory T cells (Tregs) can be targeted in cancer immunotherapy. A previous study has shown that the chemokine CCL17 and the receptor CCR4 play a role in Treg recruitment in canine urothelial carcinoma. Here, we describe the association of tumor-infiltrating Tregs with CCL17/CCR4 expression in dogs with other carcinomas. In this study, we investigated 23 dogs with mammary carcinoma, 14 dogs with oral squamous cell carcinoma, 16 dogs with pulmonary adenocarcinoma, and 8 healthy control dogs. Immunohistochemistry showed that Foxp3⁺ Tregs and CCR4⁺ cells were increased in the tumor tissues of mammary carcinoma, squamous cell carcinoma, and pulmonary adenocarcinoma, when compared with the healthy tissues. The number of CCR4⁺ cells was associated with that of Foxp3⁺ Tregs. Double immunofluorescence labeling confirmed that most tumor-infiltrating Foxp3⁺ Tregs expressed CCR4. In vitro, canine carcinoma cell lines expressed CCL17 mRNA. Quantitative RT-PCR (reverse transcriptase-polymerase chain reaction) showed that CCL17 mRNA expression in canine carcinomas was increased approximately 10- to 25-fold relative to that of healthy tissues. These results suggest that the CCL17/CCR4 axis may drive Treg recruitment in a variety of canine carcinomas. CCR4 blockade may be a potential therapeutic option for tumor eradication through Treg depletion.
Mostrar más [+] Menos [-]Palabras clave de AGROVOC
Información bibliográfica
Este registro bibliográfico ha sido proporcionado por National Agricultural Library